315 related articles for article (PubMed ID: 26915519)
21. Epidemiology of pediatric hematological malignancies in Kazakhstan: Data from Unified National Electronic Healthcare System 2014-2021.
Mussina K; Kuanova B; Syssoyev D; Gaipov A; Poddighe D; Shaikhyzada K; Aimyshev T; Galiyeva D
Eur J Pediatr; 2024 Apr; 183(4):1683-1691. PubMed ID: 38214809
[TBL] [Abstract][Full Text] [Related]
22. Ageing, exposure to pollution, and interactions between climate change and local seasons as oxidant conditions predicting incident hematologic malignancy at KINSHASA University clinics, Democratic Republic of CONGO (DRC).
Nkanga MSN; Longo-Mbenza B; Adeniyi OV; Ngwidiwo JB; Katawandja AL; Kazadi PRB; Nzonzila AN
BMC Cancer; 2017 Aug; 17(1):559. PubMed ID: 28835214
[TBL] [Abstract][Full Text] [Related]
23. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
24. Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer.
Jabagi MJ; Goncalves A; Vey N; Le Tri T; Zureik M; Dray-Spira R
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31569513
[TBL] [Abstract][Full Text] [Related]
25. [Hematologic malignancies in internal medicine, University Hospital of Souro Sanou (Burkina Faso)].
Ouédraogo SM; Hien F; Bazié W; Millogo A; Drabo YJ
Mali Med; 2011; 26(3):17-21. PubMed ID: 22766156
[TBL] [Abstract][Full Text] [Related]
26. Hematological malignancies in East Africa-Which cancers to expect and how to provide services.
Leak SA; Mmbaga LG; Mkwizu EW; Mapendo PJ; Henke O
PLoS One; 2020; 15(5):e0232848. PubMed ID: 32374771
[TBL] [Abstract][Full Text] [Related]
27. An experience with sixty cases of haematological malignancies; a clinico haematological correlation.
Idris M; Shah SH; Fareed J; Gul N
J Ayub Med Coll Abbottabad; 2004; 16(4):51-4. PubMed ID: 15762065
[TBL] [Abstract][Full Text] [Related]
28. Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohort.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
Int J Cancer; 2021 Jan; 148(2):375-384. PubMed ID: 32683691
[TBL] [Abstract][Full Text] [Related]
29. Non-lymphoma hematological malignancies in systemic lupus erythematosus.
Lu M; Bernatsky S; Ramsey-Goldman R; Petri M; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler EM; Yelin E; Bae SC; Wallace DJ; Jacobsen S; Dooley MA; Peschken CA; Alarcón GS; Nived O; Gottesman L; Criswell LA; Sturfelt G; Dreyer L; Lee JL; Clarke AE
Oncology; 2013; 85(4):235-40. PubMed ID: 24107608
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA;
J Hematol Oncol; 2021 Oct; 14(1):168. PubMed ID: 34649563
[TBL] [Abstract][Full Text] [Related]
31. Trends in hematological cancer in the elderly in Denmark, 1980-2012.
Ocias LF; Larsen TS; Vestergaard H; Friis LS; Abildgaard N; Frederiksen H;
Acta Oncol; 2016; 55 Suppl 1():98-107. PubMed ID: 26783877
[TBL] [Abstract][Full Text] [Related]
32. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
33. Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.
Monnereau A; Troussard X; Belot A; Guizard AV; Woronoff AS; Bara S; Lapôtre-Ledoux B; Iwaz J; Tretarre B; Maynadié M;
Int J Cancer; 2013 May; 132(10):2378-87. PubMed ID: 23034773
[TBL] [Abstract][Full Text] [Related]
34. The clinical and pathological features of patients with hematological neoplasms: a study of hospital-based Cancer Registry from western Turkey.
Kilciksiz S; Pehlivan M; Yilmaz EB; Payzin B; Bener S; Baloglu A
J BUON; 2011; 16(3):505-10. PubMed ID: 22006758
[TBL] [Abstract][Full Text] [Related]
35. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
[TBL] [Abstract][Full Text] [Related]
36. Contributions of a regional approach to document hematologic disease in Mexico: a 10-year experience in an open population.
Jaime-Pérez JC; Treviño-Reyna G; Aguilar-Calderón P; Cantú-Rodríguez OG; Marfil-Rivera LJ; Gómez-Almaguer D
Hematology; 2018 Dec; 23(10):803-809. PubMed ID: 30010502
[TBL] [Abstract][Full Text] [Related]
37. Nosocomial infection in adult admissions with hematological malignancies originating from different lineages: a prospective observational study.
Liu H; Zhao J; Xing Y; Li M; Du M; Suo J; Liu Y
PLoS One; 2014; 9(11):e113506. PubMed ID: 25415334
[TBL] [Abstract][Full Text] [Related]
38. Anthropometric characteristics, physical activity and risk of hematological malignancies: A systematic review and meta-analysis of cohort studies.
Psaltopoulou T; Sergentanis TN; Ntanasis-Stathopoulos I; Tzanninis IG; Riza E; Dimopoulos MA
Int J Cancer; 2019 Jul; 145(2):347-359. PubMed ID: 30614529
[TBL] [Abstract][Full Text] [Related]
39. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
40. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
